Back

Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion

31 August 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: Pharmaco intervention and mechanisms in acute coronary syndromes Thrombosis, Platelets, and Coagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Farzin Beygui

University Hospital of Caen, Caen (France)

5 More presentations in this session

Presentation thumbnail
Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention
Doctor K. Adatia (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Is there evidence of a rebound increase in platelet aggregation following withdrawal of Aspirin or Ticagrelor in patients who have previously undergone PCI and coronary stenting?
Doctor B. Hennigan (Cork, IE)
Abstract Slides
Presentation thumbnail
Effect of exercise stress test on platelet function in patients with recent acute myocardial infarction
Doctor T. Dalcoquio (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Comparative efficacy of intracoronary agents for acute treatment of coronary no-reflow: a network meta-analysis
Associate Professor G. Klappacher (Vienna, AT)
Abstract Slides
Presentation thumbnail
Late mortality after pharmaco-invasive PCI for STEMI
Professor J. French (Sydney, AU)
Abstract Slides

Access the full session

Session thumbnail
Pharmaco intervention and mechanisms in acute coronary syndromes

The Event

Event poster

ESC Congress 2019

31 August 2019 12:40 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources